These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3319571)

  • 21. Literature survey of bacterial, fungal, and Drosophila assay systems used in the evaluation of selected chemical compounds for mutagenic activity.
    Brown MM; Wassom JS; Malling HV; Shelby MD; Von Halle ES
    J Natl Cancer Inst; 1979 Apr; 62(4):841-71. PubMed ID: 155170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome aberration and sister chromatid exchange test results with 42 chemicals.
    Anderson BE; Zeiger E; Shelby MD; Resnick MA; Gulati DK; Ivett JL; Loveday KS
    Environ Mol Mutagen; 1990; 16 Suppl 18():55-137. PubMed ID: 2091924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome aberration tests with Chinese hamster cells in vitro with and without metabolic activation--a comparative study on mutagens and carcinogens.
    Ishidate M; Yoshikawa K
    Arch Toxicol Suppl; 1980; 4():41-4. PubMed ID: 7002106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collaborative studies on the Salmonella/microsome mutagenicity assay.
    Dunkel VC
    J Assoc Off Anal Chem; 1979 Jul; 62(4):874-82. PubMed ID: 387710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting rodent carcinogenicity using potency measures of the in vitro sister chromatid exchange and chromosome aberration assays.
    Schildcrout JS; Margolin BH; Zeiger E
    Environ Mol Mutagen; 1999; 33(1):59-64. PubMed ID: 10037324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotoxicity studies on sertaconazole.
    Romero A; Palacín C; Mosesso P; Hodson-Walker G; Marcos R; Batiste-Alentorn M; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):743-5. PubMed ID: 1627196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP toxicology and carcinogenesiss studies of citral (microencapsulated) (CAS No. 5392-40-5) in F344/N rats and B6C3F1 mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2003 Jan; (505):1-268. PubMed ID: 12637974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity testing of quinine with submammalian and mammalian systems.
    Münzner R; Renner HW
    Toxicology; 1983 Feb; 26(2):173-8. PubMed ID: 6344334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens.
    Tennant RW; Spalding J
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1095-100. PubMed ID: 8933059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotoxic potential and in vitro tumour-promoting potential of 2-dodecylcyclobutanone and 2-tetradecylcyclobutanone, two radiolytic products of fatty acids.
    Yamakage K; Sui H; Ohta R; Toyoizumi T; Kawakami K; Matsumoto H; Takahashi T; Sasaki K; Ikezumi M; Negishi S; Izumi K; Todoriki S; Takashi K; Furuta M
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Aug; 770():95-104. PubMed ID: 25344170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term tests in screening programs of environmental chemical carcinogens.
    Amlacher E
    Exp Pathol; 1982; 22(4):187-202. PubMed ID: 6761141
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do in vivo mammalian assays compare to in vitro assays in their ability to detect mutagens?
    Natarajan AT; Obe G
    Mutat Res; 1986 May; 167(3):189-201. PubMed ID: 3083243
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro testing for cancer-causing chemicals.
    McCann J
    Hosp Pract (Off Ed); 1983 Sep; 18(9):73-85. PubMed ID: 6411600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity of 42 chemicals in Salmonella.
    Zeiger E
    Environ Mol Mutagen; 1990; 16 Suppl 18():32-54. PubMed ID: 2091923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive exercise in comparative mutagenesis with exciting outcome or how good are mutation assays in predicting carcinogens?
    Sobels FH
    Mutat Res; 1985; 147(1-2):1-4. PubMed ID: 3919291
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of mutagenic impurities in carcinogens and noncarcinogens by high-pressure liquid chromatography and the Salmonella/microsome test.
    Donahue EV; McCann J; Ames BN
    Cancer Res; 1978 Feb; 38(2):431-8. PubMed ID: 340030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of short-term tests for carcinogenicity.
    Lave LB; Omenn GS
    Nature; 1986 Nov 6-12; 324(6092):29-34. PubMed ID: 3097548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.